ENTRY       K04936                      KO
NAME        KCNMA1
DEFINITION  potassium large conductance calcium-activated channel subfamily M alpha member 1
PATHWAY     ko04022  cGMP-PKG signaling pathway
            ko04270  Vascular smooth muscle contraction
            ko04911  Insulin secretion
            ko04970  Salivary secretion
            ko04972  Pancreatic secretion
DISEASE     H01258  Generalized epilepsy and paroxysmal dyskinesia (GEPD)
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04022 cGMP - PKG signaling pathway
                K04936  KCNMA1; potassium large conductance calcium-activated channel subfamily M alpha member 1
             Organismal Systems
              Endocrine system
               04911 Insulin secretion
                K04936  KCNMA1; potassium large conductance calcium-activated channel subfamily M alpha member 1
              Circulatory system
               04270 Vascular smooth muscle contraction
                K04936  KCNMA1; potassium large conductance calcium-activated channel subfamily M alpha member 1
              Digestive system
               04970 Salivary secretion
                K04936  KCNMA1; potassium large conductance calcium-activated channel subfamily M alpha member 1
               04972 Pancreatic secretion
                K04936  KCNMA1; potassium large conductance calcium-activated channel subfamily M alpha member 1
            Ion channels [BR:ko04040]
             Voltage-gated cation channels
              K+ channel, KCNM, KCa1.x
               K04936  KCNMA1; potassium large conductance calcium-activated channel subfamily M alpha member 1
GENES       HSA: 3778(KCNMA1)
            PTR: 466115(KCNMA1)
            PPS: 100978771(KCNMA1)
            GGO: 101153410(KCNMA1)
            PON: 100454095(KCNMA1)
            MCC: 574103(KCNMA1)
            MCF: 102139202(KCNMA1)
            MMU: 16531(Kcnma1)
            RNO: 83731(Kcnma1)
            CGE: 100764731(Kcnma1)
            HGL: 101726007(Kcnma1)
            TUP: 102471296
            CFA: 403984(KCNMA1)
            AML: 100473263
            FCA: 101099080(KCNMA1)
            PTG: 102949074(KCNMA1)
            BTA: 282573(KCNMA1)
            BOM: 102270859(KCNMA1)
            PHD: 102335142(KCNMA1)
            CHX: 102186276(KCNMA1)
            SSC: 397434(KCNMA1)
            CFR: 102509654(KCNMA1)
            BACU: 103020151(KCNMA1)
            LVE: 103072349
            ECB: 100064366(KCNMA1)
            MYB: 102242737(KCNMA1)
            MYD: 102763054(KCNMA1)
            PALE: 102894757
            MDO: 100013395(KCNMA1)
            SHR: 100922504(KCNMA1)
            OAA: 100079144(KCNMA1)
            GGA: 374065(KCNMA1)
            MGP: 100550498
            TGU: 100227091(KCNMA1)
            FAB: 101808418(KCNMA1)
            PHI: 102099683(KCNMA1)
            APLA: 101792241(KCNMA1)
            FPG: 101915596(KCNMA1)
            FCH: 102050777(KCNMA1)
            CLV: 102089237(KCNMA1)
            ASN: 102383994(KCNMA1)
            AMJ: 102564541(KCNMA1)
            PSS: 102443545(KCNMA1)
            CMY: 102943582(KCNMA1)
            ACS: 100553783
            PBI: 103065242 103067321
            XLA: 373712(kcnma1)
            XTR: 100491898(kcnma1)
            DRE: 568554(kcnma1a) 798583(kcnma1b)
            TRU: 101064381 101078302
            MZE: 101474300 101488046
            OLA: 101155390 101174692
            XMA: 102216920 102225404
            LCM: 102354999(KCNMA1)
            CMK: 103171818 103171908 103181796(kcnma1)
            BFO: BRAFLDRAFT_118038 BRAFLDRAFT_66127
            CIN: 100179948
            SPU: 578468(kcnma1)
            DME: Dmel_CG10693(slo)
            DPO: Dpse_GA10500
            DAN: Dana_GF17221
            DER: Dere_GG11309
            DPE: Dper_GL13618
            DSE: Dsec_GM26618
            DSI: Dsim_GD21120 Dsim_GD21121
            DWI: Dwil_GK10969
            DYA: Dyak_GE23506
            DGR: Dgri_GH18441
            DMO: Dmoj_GI24019
            DVI: Dvir_GJ23648
            AGA: AgaP_AGAP003709
            AAG: AaeL_AAEL003765
            CQU: CpipJ_CPIJ005769
            AME: 413994(GB17365)
            NVI: 100122182(Slo)
            TCA: 657078
            BMOR: 101738409
            API: 100169520
            PHU: Phum_PHUM221720
            ISC: IscW_ISCW007718
            CEL: CELE_Y51A2D.19(slo-1)
            CBR: CBG12923(Cbr-slo-1)
            BMY: Bm1_07555 Bm1_07560
            LOA: LOAG_10097 LOAG_12897
            TSP: Tsp_10880 Tsp_10881 Tsp_10882
            SMM: Smp_166910
            HMG: 100208455 101236626
            TAD: TRIADDRAFT_23687
            SMO: SELMODRAFT_406662(SmKC2_2) SELMODRAFT_441904(SmKC1_1) SELMODRAFT_443425(SmKC2_1) SELMODRAFT_447207(SmKC1_2)
            PPP: PHYPADRAFT_158994 PHYPADRAFT_168038 PHYPADRAFT_76052
            CRE: CHLREDRAFT_148711
            VCN: VOLCADRAFT_118002
            CSL: COCSUDRAFT_59753
            CME: CYME_CMN092C
            CCP: CHC_T00002306001 CHC_T00005066001
            DDI: DDB_G0269896(kcnma1)
            DPP: DICPUDRAFT_98532
            DFA: DFA_03502 DFA_05869(kcnma1)
            EHI: EHI_014310(37.t00010)
            EDI: EDI_240470
            ACAN: ACA1_071360
            TET: TTHERM_00187100
            PTM: GSPATT00009781001 GSPATT00024149001
            PIF: PITG_00185 PITG_03188 PITG_05304 PITG_06221 PITG_07319 PITG_10834
            GTT: GUITHDRAFT_103592 GUITHDRAFT_114916 GUITHDRAFT_119893 GUITHDRAFT_132258 GUITHDRAFT_134917 GUITHDRAFT_138739 GUITHDRAFT_144721
            NGR: NAEGRDRAFT_62012 NAEGRDRAFT_62424 NAEGRDRAFT_62425 NAEGRDRAFT_69603 NAEGRDRAFT_75355
REFERENCE   PMID:16356551
  AUTHORS   Ghatta S, Nimmagadda D, Xu X, O'Rourke ST
  TITLE     Large-conductance, calcium-activated potassium channels: structural and functional implications.
  JOURNAL   Pharmacol Ther 110:103-16 (2006)
///
